
Stuart Snyder
Examiner (ID: 19177)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1648 |
| Total Applications | 524 |
| Issued Applications | 295 |
| Pending Applications | 33 |
| Abandoned Applications | 200 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5446438
[patent_doc_number] => 20090047664
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'SPECIES DETECTION METHODS AND SYSTEMS'
[patent_app_type] => utility
[patent_app_number] => 12/190957
[patent_app_country] => US
[patent_app_date] => 2008-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6092
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047664.pdf
[firstpage_image] =>[orig_patent_app_number] => 12190957
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/190957 | Species detection methods and systems | Aug 12, 2008 | Issued |
Array
(
[id] => 6024214
[patent_doc_number] => 20110052540
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'Non-Aggregating Virus Formulation'
[patent_app_type] => utility
[patent_app_number] => 12/671950
[patent_app_country] => US
[patent_app_date] => 2008-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1898
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052540.pdf
[firstpage_image] =>[orig_patent_app_number] => 12671950
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/671950 | Non-Aggregating Virus Formulation | Aug 10, 2008 | Abandoned |
Array
(
[id] => 6159795
[patent_doc_number] => 20110159035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'S/O TYPE TRANSDERMAL IMMUNIZING AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/055989
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6972
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0159/20110159035.pdf
[firstpage_image] =>[orig_patent_app_number] => 13055989
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/055989 | S/O TYPE TRANSDERMAL IMMUNIZING AGENT | Jul 31, 2008 | Abandoned |
Array
(
[id] => 6322933
[patent_doc_number] => 20100196878
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'DUAL-RECOGNITION IMMUNOASSAY FOR THE DETECTION OF ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 12/670666
[patent_app_country] => US
[patent_app_date] => 2008-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8213
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196878.pdf
[firstpage_image] =>[orig_patent_app_number] => 12670666
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/670666 | DUAL-RECOGNITION IMMUNOASSAY FOR THE DETECTION OF ANTIBODIES | Jul 27, 2008 | Abandoned |
Array
(
[id] => 121115
[patent_doc_number] => 07709191
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'Heteroduplex tracking assay'
[patent_app_type] => utility
[patent_app_number] => 12/174141
[patent_app_country] => US
[patent_app_date] => 2008-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 35821
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709191.pdf
[firstpage_image] =>[orig_patent_app_number] => 12174141
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/174141 | Heteroduplex tracking assay | Jul 15, 2008 | Issued |
Array
(
[id] => 5290467
[patent_doc_number] => 20090023197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'Method for purifying a viral suspension'
[patent_app_type] => utility
[patent_app_number] => 12/145931
[patent_app_country] => US
[patent_app_date] => 2008-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 2222
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023197.pdf
[firstpage_image] =>[orig_patent_app_number] => 12145931
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/145931 | Method for purifying a viral suspension | Jun 24, 2008 | Issued |
Array
(
[id] => 6561298
[patent_doc_number] => 20100272706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'ANTIVIRALS'
[patent_app_type] => utility
[patent_app_number] => 12/143621
[patent_app_country] => US
[patent_app_date] => 2008-06-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 28183
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20100272706.pdf
[firstpage_image] =>[orig_patent_app_number] => 12143621
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/143621 | ANTIVIRALS | Jun 19, 2008 | Abandoned |
Array
(
[id] => 6425379
[patent_doc_number] => 20100151445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'Multiplex Method for Detecting an Infection'
[patent_app_type] => utility
[patent_app_number] => 12/600297
[patent_app_country] => US
[patent_app_date] => 2008-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 12042
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20100151445.pdf
[firstpage_image] =>[orig_patent_app_number] => 12600297
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/600297 | Multiplex Method for Detecting an Infection | Jun 5, 2008 | Abandoned |
Array
(
[id] => 6506072
[patent_doc_number] => 20100216116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'VIRAL LATENCY MODEL'
[patent_app_type] => utility
[patent_app_number] => 12/663539
[patent_app_country] => US
[patent_app_date] => 2008-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12406
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0216/20100216116.pdf
[firstpage_image] =>[orig_patent_app_number] => 12663539
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/663539 | VIRAL LATENCY MODEL | Jun 5, 2008 | Abandoned |
Array
(
[id] => 4710615
[patent_doc_number] => 20080299141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-04
[patent_title] => 'Raccoon Poxvirus Expressing Genes of Porcine Virus'
[patent_app_type] => utility
[patent_app_number] => 12/128240
[patent_app_country] => US
[patent_app_date] => 2008-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12625
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0299/20080299141.pdf
[firstpage_image] =>[orig_patent_app_number] => 12128240
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/128240 | Raccoon Poxvirus Expressing Genes of Porcine Virus | May 27, 2008 | Abandoned |
Array
(
[id] => 6296316
[patent_doc_number] => 20100160420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'NOVEL SIMIAN T-CELL LYMPHOTROPIC VIRUS'
[patent_app_type] => utility
[patent_app_number] => 12/600995
[patent_app_country] => US
[patent_app_date] => 2008-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 37330
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20100160420.pdf
[firstpage_image] =>[orig_patent_app_number] => 12600995
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/600995 | Simian T-cell lymphotropic virus | May 19, 2008 | Issued |
Array
(
[id] => 4812836
[patent_doc_number] => 20080193467
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'DENDRITIC CELL POTENTIATION'
[patent_app_type] => utility
[patent_app_number] => 12/103362
[patent_app_country] => US
[patent_app_date] => 2008-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 14387
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193467.pdf
[firstpage_image] =>[orig_patent_app_number] => 12103362
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/103362 | DENDRITIC CELL POTENTIATION | Apr 14, 2008 | Abandoned |
Array
(
[id] => 11224500
[patent_doc_number] => 09452209
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-27
[patent_title] => 'Influenza vaccine'
[patent_app_type] => utility
[patent_app_number] => 12/103136
[patent_app_country] => US
[patent_app_date] => 2008-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 43
[patent_no_of_words] => 59442
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12103136
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/103136 | Influenza vaccine | Apr 14, 2008 | Issued |
Array
(
[id] => 83090
[patent_doc_number] => 07741027
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-06-22
[patent_title] => 'Amplification of HIV-1 sequences for detection of sequences associated with drug-resistance mutations'
[patent_app_type] => utility
[patent_app_number] => 12/100350
[patent_app_country] => US
[patent_app_date] => 2008-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13889
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 231
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/741/07741027.pdf
[firstpage_image] =>[orig_patent_app_number] => 12100350
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/100350 | Amplification of HIV-1 sequences for detection of sequences associated with drug-resistance mutations | Apr 8, 2008 | Issued |
Array
(
[id] => 6314427
[patent_doc_number] => 20100111990
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected Women'
[patent_app_type] => utility
[patent_app_number] => 12/532307
[patent_app_country] => US
[patent_app_date] => 2008-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7734
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20100111990.pdf
[firstpage_image] =>[orig_patent_app_number] => 12532307
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/532307 | Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected Women | Mar 16, 2008 | Abandoned |
Array
(
[id] => 5584960
[patent_doc_number] => 20090104162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-04-23
[patent_title] => 'Attenuated reoviruses for selection of cell populations'
[patent_app_type] => utility
[patent_app_number] => 12/075751
[patent_app_country] => US
[patent_app_date] => 2008-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13349
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20090104162.pdf
[firstpage_image] =>[orig_patent_app_number] => 12075751
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/075751 | Attenuated reoviruses for selection of cell populations | Mar 11, 2008 | Issued |
Array
(
[id] => 4676233
[patent_doc_number] => 20080213863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'Method of Controlling Viral Outbreak'
[patent_app_type] => utility
[patent_app_number] => 12/043529
[patent_app_country] => US
[patent_app_date] => 2008-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7937
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213863.pdf
[firstpage_image] =>[orig_patent_app_number] => 12043529
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/043529 | Method of Controlling Viral Outbreak | Mar 5, 2008 | Abandoned |
Array
(
[id] => 11464971
[patent_doc_number] => 09581595
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-02-28
[patent_title] => 'Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy'
[patent_app_type] => utility
[patent_app_number] => 12/527863
[patent_app_country] => US
[patent_app_date] => 2008-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14803
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1128
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12527863
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/527863 | Compositions and methods for determining whether a subject would benefit from co-receptor inhibitor therapy | Feb 25, 2008 | Issued |
Array
(
[id] => 4852557
[patent_doc_number] => 20080318300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Method for Inactivating Viruses With Slightly Acidic Arginine'
[patent_app_type] => utility
[patent_app_number] => 12/030321
[patent_app_country] => US
[patent_app_date] => 2008-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7028
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318300.pdf
[firstpage_image] =>[orig_patent_app_number] => 12030321
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/030321 | Method for inactivating viruses with slightly acidic arginine | Feb 12, 2008 | Issued |
Array
(
[id] => 4954531
[patent_doc_number] => 20080187555
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-07
[patent_title] => 'New Vaccine Formulations'
[patent_app_type] => utility
[patent_app_number] => 12/027776
[patent_app_country] => US
[patent_app_date] => 2008-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13249
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20080187555.pdf
[firstpage_image] =>[orig_patent_app_number] => 12027776
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/027776 | Vaccine formulations | Feb 6, 2008 | Issued |